Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis

Publication date: July 2021Source: Multiple Sclerosis and Related Disorders, Volume 52Author(s): Stephanie N. Blandford, Dylan A. Galloway, John B. Williams, Shane Arsenault, Janet Brown, Gregg MacLean, G.R. Wayne Moore, Jane Barron, Michelle Ploughman, Fraser Clift, Mark Stefanelli, Craig S. Moore
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research